Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder characterized by mucocutaneous telangiectases and arteriovenous malformations (AVMs). The disease rarely presents in the neonatal period, primarily manifesting with epistaxis and gastrointestinal bleeding in adulthood. Occasionally, HHT can also present with symptoms related to AVMs in the cerebral, pulmonary or gastrointestinal vasculature. In prior reports, intracranial hemorrhage (ICH) secondary to cerebral AVM in neonates with HHT has been catastrophic and uniformly fatal. Here we report a case of a newborn with HHT and ICH from a suspected AVM who survived with aggressive medical management and surgical intervention, and provide a comprehensive review of the literature on ICH in neonates with HHT.
Introduction
Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder with a high degree of penetrance and variable expressivity. It is characterized by mucocutaneous telangiectases and arteriovenous malformations (AVMs) most often found in the cerebral, pulmonary and gastrointestinal circulations. 1 Symptoms are rare in children and typically present in early adulthood with epistaxis and gastrointestinal bleeding by the fifth or sixth decade. In the adult population with HHT, 20% have cerebrovascular malformations with the annual risk of intracranial hemorrhage (ICH) from unruptured AVMs of 2-4%. 2 The prevalence of cerebral AVMs among children with HHT is unknown and ICH secondary to HHT has been rarely reported in neonates. In these cases, the ICH is catastrophic and uniformly fatal, with most cases of AVM diagnosed on autopsy.
2,3 Here we report a newborn found to have HHT presenting with seizures and diagnosed with ICH from a suspected AVM who survived with aggressive medical management and surgical intervention.
Case
A 37-week gestation female was born via urgent Cesarean section to a primiparous 28-year-old woman secondary to late fetal decelerations. Maternal history was notable for HHT with normal prenatal ultrasounds. At delivery, the infant had poor respiratory effort and was transferred to the neonatal intensive care unit for further management. On admission, the infant's weight and occipital-frontal circumference was 50th percentile with an open and flat fontanelle. Her exam was otherwise notable for moderate respiratory distress with normal cardiac exam. No skin telangiectases were noted. Chest X-ray was consistent with transient tachypnea of the newborn and she was quickly weaned from respiratory support but was noted to have difficulty with oral feeds and early jaundice. On the second day of life, the infant developed seizures, persistent downward deviation of the eyes and a bulging fontanelle. A non-sedated magnetic resonance imaging (MRI) revealed a massive hematoma with mass effect within the fourth ventricle, obstructive hydrocephalus and transverse cerebral venous sinus thrombosis (Figures 1a and b) . Computed tomography (CT) venogram revealed partial thrombosis of the transverse sinuses (Figures 2a and b) . CT angiography and magnetic resonance angiography (MRA) failed to define a source for the bleeding, but because of the maternal history, an AVM in the fourth ventricle was suspected. An emergent external ventriculostomy was placed to decompress the ventricles and the clinical status of the infant improved. Postoperatively the infant was managed with aggressive hydration to augment flow through the partially thrombosed transverse sinuses and relative hypernatremia and albumin infusions to provide an osmotic gradient to decrease cerebral edema. An internal ventricular access device was later placed followed by a ventriculoperitoneal shunt at 6 weeks. Serial head ultrasounds demonstrated persistent patency of the cerebral venous sinus system with complete resolution of the partial transverse sinus thromboses on CT venogram at 2 weeks. Genetic studies revealed a heterozygous mutation of c.872_883del12bp in the Endoglin gene; the same mutation was found in the mother. Repeat MRA at 3 months of age revealed near resolution of the fourth ventricle thrombus (Figures 3a and b) . Follow-up MRA at 1 year revealed no apparent AVM. The infant is now 13 months old and by report suffers from mild coordination difficulties but is otherwise developmentally appropriate.
Discussion
HHT rarely presents with ICH in the neonatal period. Although children and adult patients with HHT who have ICH typically have good functional outcomes with minimal residual deficits, the contrary has been observed in the neonatal population. [4] [5] [6] [7] [8] [9] There are seven reports in the literature of neonates and young infants with known or suspected HHT with symptomatic cerebral AVMs. Their outcomes are presented in Table 1 of the Supplementary Information. To the author's knowledge, this case represents the first reported survival of a neonate with HHT and ICH. The locality of the AVM to the fourth ventricle resulting in intraventricular hemorrhage may have been this infant's life-saving feature, which allowed for emergent surgical intervention. Given the associated mortality risks of ICH in neonates with HHT, this case highlights the importance of early neuroimaging to search for cerebral AVMs in this at-risk population. Although it has been previously recommended that genetic screening via amniocentesis or chorionic villous sampling, as well as prenatal imaging such as MRI should be provided for children of HHT families by 1 year of age, this case argues that even earlier screening for detection of the disease-causing mutation and its manifestations may be beneficial and potentially life-saving. 1 Given the genetic heterogeneity of the disease, genetic analysis does not always establish the diagnosis of HHT due to unknown or complex mutations. Therefore, even without genetic confirmation of HHT, consideration should be given to delivery in a hospital that is able to provide tertiary medical care and emergency neurosurgical interventions. Such infants should undergo strict monitoring for subtle abnormalities that may indicate early signs of ICH. If signs of ICH are present, imaging with MRI or CT, rather than ultrasound, should be considered to provide the best details of the anatomy and pathology and to better visualize the subarachnoid space and venous sinuses.
In this case, although posthemorrhage imaging failed to define an AVM, it is not uncommon for small AVMs near the ventricular wall to spontaneously thrombose due to the pressure of the clot and subsequent hydrocephalus. These types of AVMs that are not visualized by serial cerebral angiography are known as 'angiographically occult intracranial vascular malformations' and are well described in the literature. 10 Therefore, with the diagnosis of HHT and the location of the hemorrhage, AVM remains the most likely diagnosis. A previous study reported the occurrence of ICH in an older child with a family history of HHT whose AVM was not present on initial angiogram or during evacuation of the hematoma, although was identified on follow-up angiography, confirmed that after hemorrhage these lesions may be obscured by the ictal event. 4 In conclusion, we present the first reported case of survival in a neonate with HHT and ICH from a suspected AVM. There is no question that ICH in these infants can be catastrophic with a reported high level of mortality. It is our recommendation that infants born to a parent with HHT undergo an early genetic and radiological evaluation for HHT and its manifestations. Without question, the serendipitous transient respiratory distress that affected this infant requiring transitioning in the neonatal intensive care unit with close monitoring was life-saving. Without early detection, imaging and aggressive management the outcome of this case could have proven devastating.
